The AIDS Drug Assistance Program (ADAP) is supported through a combination of State and Federal funding. The Department of Health first received Federal HIV funds in 1987 for the purpose of purchasing zidovudine (AZT), the only antiretroviral available at that time for HIV treatment. The General Assembly first appropriated State funding for HIV medication in 1990. All HIV/AIDS related information is kept strictly confidential.
The Virginia AIDS Drug Assistance Program (ADAP) provides medication for the treatment of HIV/AIDS to individuals without insurance coverage or third party benefits for ADAP medications. The individual must also meet financial eligibility requirements as established by the Department of Health.
In 1996, an ADAP Advisory Committee was created. The committee is comprised of HIV/AIDS medical providers, a pharmacist, and consumers. The committee advises VDH on changes to the formulary, changes in eligibility criteria, adherence issues, and educational concerns. The committee reviews data on ADAP utilization and assess budgetary implications of trends and program changes.
Questions or comments?
Contact HIV/STD/Viral Hepatitis Hotline